Related Experiment Video
Updated: Aug 18, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.0K
Platelets from 13-lined ground squirrels are resistant to cold storage lesions
N Splinter1, A Mancosky1, C Laffin1
1Biology Department, University of Wisconsin-La Crosse, 1725 State St., La Crosse, WI, 54601, USA.
Summary
Ground squirrel platelets resist cold storage damage, unlike human platelets. This suggests hibernating animals have natural mechanisms for preserving platelet function during torpor and arousal.
Area of Science:
- Comparative physiology
- Hematology
- Mammalian hibernation
Background:
- Hibernation involves decreased heart rate and blood flow, increasing clot risk.
- Mammalian platelets face cold storage lesions and rapid clearance, limiting human platelet transfusion shelf life to 7 days.
- Ground squirrels sequester platelets in the liver during torpor, releasing them upon arousal.
Purpose of the Study:
- To investigate the resistance of ground squirrel platelets to cold storage lesions compared to human platelets.
- To elucidate potential mechanisms underlying platelet cold adaptation in hibernating mammals.
Main Methods:
- Human and ground squirrel platelets were stored at room temperature or 4°C.
- Analysis included phosphatidylserine exposure, caspase activation, and sialic acid residue cleavage.
- Phagocytosis assays using HepG2 cells were performed post-storage.
Main Results:
- Human platelets stored at 4°C showed increased phosphatidylserine exposure, caspase activation, and desialylation.
- Cold-stored human platelets were readily phagocytosed by HepG2 cells.
- Ground squirrel platelets exhibited minimal cold storage lesions, with low phagocytosis rates even after cold exposure.
Conclusions:
- Ground squirrel platelets demonstrate remarkable resistance to cold storage lesions compared to human platelets.
- This resistance suggests a natural adaptation in hibernating species for maintaining platelet function during torpor.
- Findings may inform strategies for improving human platelet storage and transfusion viability.

